Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Temple Stay Improves Intestinal Microbiome Profile in Patients With Irritable Bowel Syndrome

NCT05999500 is registered in ClinicalTrials.gov with DongGuk University as lead sponsor.

NCT NCT05999500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05999500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Temple Stay Improves Intestinal Microbiome Profile in Patients With Irritable Bowel Syndrome
Lead sponsor
DongGuk University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2023
Completion date
December 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome, microbial colonization